GSK on Wednesday announced it is restructuring an existing collaboration agreement with German biotech CureVac, focusing on their investigational mRNA vaccines for influenza and COVID-19 while withdrawing from other infectious disease projects. Under the amended...
Novavax’s updated vaccine will be available at vaccination centers across Taiwan GAITHERSBURG, Md., Dec. 18, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced...
The third quarter of 2023 has been a mix of positive news and stumbling blocks for some of the biggest names in biopharma. With layoffs continuing at a brisk pace for biotechs, both big and small, some companies have been seeing a successful quarter while some have...
In the study published in npj Vaccines, titled “Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability,” researchers led by Lizhou Zhang et al. from Boston Children’s Hospital, Harvard Medical School, and...
Pfizer (PFE.N), BioNTech (22UAy.DE) and biotech firm Promosome told a federal judge in San Diego, California that they have agreed to end Promosome’s lawsuit accusing the COVID-19 vaccine makers of infringing a patent related to messenger RNA technology. The...
